(EMAILWIRE.COM, November 13, 2019 ) Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples. This metabolomics technology market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography.

The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving a metabolomics technology market growth. New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the Metabolomics Market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900

The research report discusses key market drivers, restraints, opportunities, and challenges in the global metabolomics technology market and its submarkets.

key players operating in the Global Metabolomics Market;

The global metabolomics technology market is highly competitive and fragmented in nature. Prominent players in the global market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.)

Thermo Fisher Scientific, Inc. (U.S.) held the leading position in the global market. Its prominence in this market can be attributed to its diversified product portfolio that includes a wide range of products for metabolomics instrumentation tools and services. The company strongly invests in R&D activities to improve its existing product portfolio, as it has a strong pipeline of products for the growing market.

Major Drivers Impacting the Metabolomics Market;

• Availability of government and private funding
• Increasing pharmaceutical and biotech R&D expenditure
• Technological advancements
• Growing demand for personalized medicine
• Increasing use of metabolomics in toxicology testing

Key Questions;

• Most of the metabolomics market players have new product launch and product enhancements as the key growth strategies. Where will it take the industry in the mid to long term?

• How are the potential areas for investment using strategic evaluation in the metabolomics technology market?
Global Metabolomics Market Segmentation:

Based on product & service, the market is segmented into metabolomics instruments and metabolomics bioinformatics tools & services. Metabolomics bioinformatics tools & services is expected to grow at the highest CAGR during the forecast period. The ability of metabolome analysis software tools for interpreting the results of analytical experiments and understand the potential of metabolomics data generated from analytical tools are expected to drive the growth of this segment.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=900

Metabolomics Market by Geography
• North America
• Europe
• Asia Pacific (APAC)
• Latin America
• Middle East & Africa